Brainify.AI Company
AI/ML EEG biomarker platform for novel treatment development for depression in women, which increases the likelihood of new drug approval.
Total Funding:
1600000
Headquarters:
New York, New York, United States
Funding Status:
Seed
Employee Number:
11-50
Last Funding Type:
Pre-Seed
Technology:
['BioTech & HealthTech']
Investor Type:
info@brainify.ai
Last Funding Date:
2023-01-10
Founded Date:
2021-02-27
Industry:
NeuroTech